0000911916-17-000020.txt : 20170104 0000911916-17-000020.hdr.sgml : 20170104 20170104161922 ACCESSION NUMBER: 0000911916-17-000020 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170103 FILED AS OF DATE: 20170104 DATE AS OF CHANGE: 20170104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lawton Alison Frances CENTRAL INDEX KEY: 0001542650 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 17505675 MAIL ADDRESS: STREET 1: 39 ROBINSON ROAD CITY: LEXINGTON STATE: MA ZIP: 02420 FORMER NAME: FORMER CONFORMED NAME: LAWTON ALISON FRANCIS DATE OF NAME CHANGE: 20120216 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2017-01-03 0001348649 CoLucid Pharmaceuticals, Inc. CLCD 0001542650 Lawton Alison Frances C/O COLUCID PHARMACEUTICALS, INC. 222 THIRD STREET CAMBRIDGE MA 02142 1 0 0 0 Stock Option (Right to Buy) 36.20 2017-01-03 4 A 0 658 30.40 A 2017-01-03 2027-01-03 Common Stock 658 658 D This option was issued to the reporting person pursuant to the CoLucid Pharmaceuticals, Inc. Non-Employee Director Compensation Policy in lieu of cash compensation of $20,000. /s/ Christine G. Long, Attorney-in-Fact for Alison Lawton (power of attorney previously filed) 2017-01-04